Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Quality Improvement Initiatives to Improve Transfusion Safety and Efficiency for Patients Receiving Daratumumab

Richard Curtis Godby, MD, Tammy Gray, BS, Hollie Christopher, BS, MLS, Lance A. Williams, III, MD, Marisa B. Marques, MD

Blood (2019) 134 (Supplement_1): 2100.

https://doi.org/10.1182/blood-2019-126958

Published: 2019

Journal Articles

Transfusion Support in Patients with Sickle Cell Anemia Undergoing Haploidentical Hematopoietic Cell Transplantation

Dilan A Patel, MD, Deva Sharma, MD MS, Jennifer Andrews, MDMSc, Adetola A. Kassim, MDMS

Blood (2019) 134 (Supplement_1): 3686.

https://doi.org/10.1182/blood-2019-131942

Published: 2019

Journal Articles

Genetic Association Studies of Red Blood Cell Transfusion Related Alloimmunization: A Systematic Review and Meta-Analysis

Jorn Gerritsma, MD, Ilja Oomen, BSc, Sanne Meinderts, PhD, C. Ellen van der Schoot, MD PhD, Bart J. Biemond, MD PhD, Johanna G van der Bom, MD PhD, Karin Fijnvandraat, MD PhD

Blood (2019) 134 (Supplement_1): 2459.

https://doi.org/10.1182/blood-2019-128199

Published: 2019

Journal Articles

Genotypic and Alelicas Frequencies of the ABO and Rh Systems in the State of Rio Grande Do Norte, Northeast of Brazil

Linduarte Varela Morais, Aldair Sousa Paiva, PhDMD, Valéria SF Sales, PhD, Geraldo Barroso Cavalcanti, Jr., PhD

Blood (2019) 134 (Supplement_1): 4990.

https://doi.org/10.1182/blood-2019-123802

Published: 2019

Journal Articles

Validation of Daraex to Resolve Daratumumab-Induced Interferences in Pre-Transfusion Screen Tests

Maria Tenorio, PhD, Gemma Moreno Jiménez, MD, Valentín García Gutiérrez, PhD, Ana Jiménez, Maria Jesús Blanchard, MD, Ana Vallés, Sandra López, Pilar Herrera, MD, Javier Lopez Jimenez, MD PhD, Anabelle Chinea, MD

Blood (2019) 134 (Supplement_1): 4983.

https://doi.org/10.1182/blood-2019-131345

Published: 2019

Journal Articles

Red Cell Exchange: A Concise Review of Indications and Management

Elizabeth Biller, Yong Zhao, Lejla Music-Aplenc, MD, Mary Berg, MD, Lisa N Boggio, MD MS, Theresa Boyd, Kelley Capocelli, Deanna C Fang, Scott A Koepsell, MD, PhD, FCAP, Huy P. Pham, MD, M.P.H., Angela Treml, John Weiss, Geoffrey D. Wool, MD PhD, Beverly W Baron

Blood (2017) 130 (Supplement 1): 4800.

https://doi.org/10.1182/blood.V130.Suppl_1.4800.4800

Published: 2017

Journal Articles

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

Nancy Robitaille, MD, Yves D. Pastore, MD, Anne-Julie Landry, M.Sc, Catherine Latour, MD, Josée Lavoie, M.Sc, Geneviève Laflamme, M.Sc, Josée Perreault, PhD, Maryse St-Louis, PhD

Blood (2016) 128 (22): 2486.

https://doi.org/10.1182/blood.V128.22.2486.2486

Published: 2016

Journal Articles

International Validation of a Dithiothreitol (DTT)-Based Method to Resolve the Daratumumab Interference with Blood Compatibility Testing

Blood (2015) 126 (23): 3567.

https://doi.org/10.1182/blood.V126.23.3567.3567

Published: 2015

Journal Articles

Outcomes and Management of Red Blood Cell Transfusions in Multiple Myeloma Patients Treated with Daratumumab

Blood (2015) 126 (23): 3571.

https://doi.org/10.1182/blood.V126.23.3571.3571

Published: 2015

Journal Articles

Designated Donor Program Enrollment Does Not Affect Red Blood Cell Alloimmunization Rates in Children with Sickle Cell Disease on Chronic Transfusion Therapy

Ronald Jackups, MD PhD, Debbie Woods, RN, MSN, CPNP, Robert J. Hayashi, MD, Monica L. Hulbert, MD

Blood (2014) 124 (21): 4291.

https://doi.org/10.1182/blood.V124.21.4291.4291

Published: 2014

Journal Articles

Prophylactic Rh and Kell Antigen Matching Significantly Decreases Rates of Alloimmunization in Transfusion Dependent MDS Patients

Aliza Saskin, Yulia Lin, MD, Richard A. Wells, MD DPhil, Martha Lenis, Alex Mamedov, Jeannie Callum, MD, Rena Buckstein, MD FRCPC

Blood (2014) 124 (21): 4297.

https://doi.org/10.1182/blood.V124.21.4297.4297

Published: 2014

Journal Articles

Red Cell Alloimmunization in Sickle Cell Disease: Benefit of Extended Crossmatching in Adults

Dianne Pulte, Julie Kay, Mary Harach, Nguyet Le, Jay H. Herman, MD

Blood (2012) 120 (21): 4761.

https://doi.org/10.1182/blood.V120.21.4761.4761

Published: 2012

Journal Articles

A Randomized Trial of the Safety and Benefit of Transfusion Vs. Standard Care In the Prevention of Sickle Cell-Related Complications In Adults: a Preliminary Report From the Phase II NHLBI Comprehensive Sickle Cell Centers (CSCC) Study of Neuropsychological Dysfunction and Neuroimaging Abnormalities In Neurologically Intact Adult Patients with Sickle Cell Disease

Blood (2010) 116 (21): 3221.

https://doi.org/10.1182/blood.V116.21.3221.3221

Published: 2010

Journal Articles

The Frequency of Red Cells with a Spontaneously Appearing XK-Null (McLeod-like) Phenotype Is Normal In Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

David J Araten, MD, Leah Zamechek, Gregory Halverson

Blood (2010) 116 (21): 816.

https://doi.org/10.1182/blood.V116.21.816.816

Published: 2010

Journal Articles

Chronic Granulomatous Disease and Mcleod Syndrome: Single Center Report of Four Cases.

Nizar Mahlaoui, MS, MSc, Marie-Dominique Dumont, MD, Thierry Peyrard, Pharm, D, Stephane Blanche, MD, PhD, Alain Fischer, MD, PhD

Blood (2009) 114 (22): 3595.

https://doi.org/10.1182/blood.V114.22.3595.3595

Published: 2009

Journal Articles

Efficacy and Cost-Effectiveness of a Limited Phenotype Matching Transfusion Protocol for Children with Sickle Cell Disease

Jerry E Squires, MD, PhD, Vinu Jyothi, MBBS, Sherron M. Jackson, MD, Miguel Abboud, MD, Ram Kalpatthi, MD

Blood (2008) 112 (11): 3043.

https://doi.org/10.1182/blood.V112.11.3043.3043

Published: 2008

Journal Articles

Spontaneously Arising Red Cells with a McLeod-Like Phenotype in Normal Donors

David J. Araten, MD, Katie J Sanders, Jeffrey Pu, Soohee Lee

Blood (2008) 112 (11): 2883.

https://doi.org/10.1182/blood.V112.11.2883.2883

Published: 2008

Journal Articles

Alloimmunization Does Not Modify the Clinical Profile of Sickle Cell Disease Patients from Salvador-Brazil

Angela Zanette, Karla O. Mota, Marilda Souza Goncalves, Laise Vilasboas Schettini, Lais Magalhaes Aguiar, Claudio Jose Freitas Brandão, Ana Cláudia Neves Azevedo, Luciana Nogueira, Sérgio Arruda

Blood (2008) 112 (11): 4799.

https://doi.org/10.1182/blood.V112.11.4799.4799

Published: 2008

Journal Articles

Beta-Thalassemia Intermedia Complicated by Autoimmune Hemolytic Anemia.

Chantal Cassis, MD, Hassan Huwait, MD, Rene P. Michel, MD, Margaret Warner, MD

Blood (2006) 108 (11): 3818.

https://doi.org/10.1182/blood.V108.11.3818.3818

Published: 2006

Journal Articles

Transplantation without Hemolysis in a Kell Antigen Positive Patient Undergoing Peripheral Hematopoietic Stem Cell Transplant from a Donor with Anti-Kell Antibodies.

Regina D. Crawford, MD, David Krugh, William Blum, MD, Steven Devine, MD

Blood (2006) 108 (11): 4137.

https://doi.org/10.1182/blood.V108.11.4137.4137

Published: 2006

NARROW

Quality Improvement Initiatives to Improve Transfusion Safety and Efficiency for Patients Receiving Daratumumab

Transfusion Support in Patients with Sickle Cell Anemia Undergoing Haploidentical Hematopoietic Cell Transplantation

Genetic Association Studies of Red Blood Cell Transfusion Related Alloimmunization: A Systematic Review and Meta-Analysis

Genotypic and Alelicas Frequencies of the ABO and Rh Systems in the State of Rio Grande Do Norte, Northeast of Brazil

Validation of Daraex to Resolve Daratumumab-Induced Interferences in Pre-Transfusion Screen Tests

Red Cell Exchange: A Concise Review of Indications and Management

Blood Group Genotyping to Prevent Alloimmunization in Children with Sickle Cell Disease

International Validation of a Dithiothreitol (DTT)-Based Method to Resolve the Daratumumab Interference with Blood Compatibility Testing

Outcomes and Management of Red Blood Cell Transfusions in Multiple Myeloma Patients Treated with Daratumumab

Designated Donor Program Enrollment Does Not Affect Red Blood Cell Alloimmunization Rates in Children with Sickle Cell Disease on Chronic Transfusion Therapy

Prophylactic Rh and Kell Antigen Matching Significantly Decreases Rates of Alloimmunization in Transfusion Dependent MDS Patients

Red Cell Alloimmunization in Sickle Cell Disease: Benefit of Extended Crossmatching in Adults

The Frequency of Red Cells with a Spontaneously Appearing XK-Null (McLeod-like) Phenotype Is Normal In Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Chronic Granulomatous Disease and Mcleod Syndrome: Single Center Report of Four Cases.

Efficacy and Cost-Effectiveness of a Limited Phenotype Matching Transfusion Protocol for Children with Sickle Cell Disease

Spontaneously Arising Red Cells with a McLeod-Like Phenotype in Normal Donors

Alloimmunization Does Not Modify the Clinical Profile of Sickle Cell Disease Patients from Salvador-Brazil

Beta-Thalassemia Intermedia Complicated by Autoimmune Hemolytic Anemia.

Transplantation without Hemolysis in a Kell Antigen Positive Patient Undergoing Peripheral Hematopoietic Stem Cell Transplant from a Donor with Anti-Kell Antibodies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only